Marketing

Brand & Demand: Frost & Sullivan’s Tactical Marketing Services Fuel B2B Pipeline Growth Amid Economic VolatilityBrand & Demand: Frost & Sullivan’s Tactical Marketing Services Fuel B2B Pipeline Growth Amid Economic Volatility

Brand & Demand: Frost & Sullivan’s Tactical Marketing Services Fuel B2B Pipeline Growth Amid Economic Volatility

Proven programs help companies stay visible, engage high-value buyers, and deliver measurable ROI - even in a downturn LONDON, April…

4 hours ago
Sprout Social Propels Brands into a New Era of Influence with AI-Powered Innovations to its Influencer Marketing PlatformSprout Social Propels Brands into a New Era of Influence with AI-Powered Innovations to its Influencer Marketing Platform

Sprout Social Propels Brands into a New Era of Influence with AI-Powered Innovations to its Influencer Marketing Platform

April 14, 2025 09:01 ET  | Source: Sprout Social, Inc AI-powered natural language discovery will allow marketers to identify creators…

2 days ago
MEXC and BNB Chain Strengthen Ties to Empower Token Listings & MarketingMEXC and BNB Chain Strengthen Ties to Empower Token Listings & Marketing

MEXC and BNB Chain Strengthen Ties to Empower Token Listings & Marketing

VICTORIA, Seychelles, April 9, 2025 /PRNewswire/ -- MEXC, a leading global cryptocurrency exchange, announced a collaboration with BNB Chain. Through…

7 days ago
SMARTIES 2025: The Ultimate Stage for Marketing Excellence – Now Accepting EntriesSMARTIES 2025: The Ultimate Stage for Marketing Excellence – Now Accepting Entries

SMARTIES 2025: The Ultimate Stage for Marketing Excellence – Now Accepting Entries

NEW YORK, April 7, 2025 /PRNewswire/ -- The 2025 SMARTIES™ Awards are now open for entries, inviting brands, agencies, and…

1 week ago
TREATMENT.COM AI INC. EXTENDS TERM OF MARKETING SERVICES PROVIDED BY I2I MARKETING GROUPTREATMENT.COM AI INC. EXTENDS TERM OF MARKETING SERVICES PROVIDED BY I2I MARKETING GROUP

TREATMENT.COM AI INC. EXTENDS TERM OF MARKETING SERVICES PROVIDED BY I2I MARKETING GROUP

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES March 14, 2025…

1 month ago
2X Invests in AI-Enabled Marketing Solutions Through Strategic Partnership with Copy.ai2X Invests in AI-Enabled Marketing Solutions Through Strategic Partnership with Copy.ai

2X Invests in AI-Enabled Marketing Solutions Through Strategic Partnership with Copy.ai

MALVERN, Pa., Feb. 18, 2025 (GLOBE NEWSWIRE) -- 2X, a leading provider of marketing as a service (MaaS), today announced…

2 months ago
ONE Advertising and Communication Services Ltd. Wins Gold for ‘Khate Raho Khushi Se’ Campaign at Adgully’s Marketing & Advertising Awards 2025ONE Advertising and Communication Services Ltd. Wins Gold for ‘Khate Raho Khushi Se’ Campaign at Adgully’s Marketing & Advertising Awards 2025

ONE Advertising and Communication Services Ltd. Wins Gold for ‘Khate Raho Khushi Se’ Campaign at Adgully’s Marketing & Advertising Awards 2025

NEW DELHI, Feb. 14, 2025 /PRNewswire/ -- ONE Advertising and Communication Services Ltd. has been honoured with a Gold Award for…

2 months ago
Valneva Receives Marketing Authorization in the UK for the Worlds First Chikungunya Vaccine, IXCHIQValneva Receives Marketing Authorization in the UK for the Worlds First Chikungunya Vaccine, IXCHIQ

Valneva Receives Marketing Authorization in the UK for the Worlds First Chikungunya Vaccine, IXCHIQ

Saint Herblain (France), February 5, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced…

2 months ago
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.

LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement…

3 months ago
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.

LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement…

3 months ago